Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer

Saved in:
Bibliographic Details
Published in:Molecular Oncology
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553978855292928
collection WordPress RSS
FRELIP Feed Integration
container_title Molecular Oncology
description
discipline_display Oncology
discipline_facet Oncology
format Online Article
RSS Article
genre Journal Article
id rss_article:92792
institution FRELIP
journal_source_facet Molecular Oncology
last_indexed 2026-06-20T21:45:31.151Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer
Oncology
General
Oncology
sub_discipline_display General
sub_discipline_facet General
subject_display Oncology
General
Oncology
subject_facet Oncology
General
Oncology
title Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer
title_alt Mediciones longitudinales de aneuploidía genómica en ADN libre circulante para predecir la falta de beneficio de pembrolizumab en pacientes con cáncer urotelial metastásico
Mesures longitudinales de l'aneuploïdie génomique dans l'ADN acellulaire circulant pour prédire l'absence de bénéfice du pembrolizumab chez les patients atteints de cancer urothélial métastatique
Medições longitudinais de aneuploidia genômica em DNA livre de células circulantes para prever falta de benefício de pembrolizumabe em pacientes com câncer urotelial metastático
title_auth Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer
title_es_txt Mediciones longitudinales de aneuploidía genómica en ADN libre circulante para predecir la falta de beneficio de pembrolizumab en pacientes con cáncer urotelial metastásico
title_fr_txt Mesures longitudinales de l'aneuploïdie génomique dans l'ADN acellulaire circulant pour prédire l'absence de bénéfice du pembrolizumab chez les patients atteints de cancer urothélial métastatique
title_full Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer
title_fullStr Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer
title_full_unstemmed Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer
title_pt_txt Medições longitudinais de aneuploidia genômica em DNA livre de células circulantes para prever falta de benefício de pembrolizumabe em pacientes com câncer urotelial metastático
title_short Longitudinal genome‐wide aneuploidy measurements in circulating cell‐free DNA to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer
title_sort longitudinal genome‐wide aneuploidy measurements in circulating cell‐free dna to predict lack of benefit from pembrolizumab in patients with metastatic urothelial cancer
topic Oncology
General
Oncology
url https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70272?af=R